Annual accounts
Total Exemption Full accounts
30/09/2026Filing deadline
Made up to 31/12/2024Due 30/09/2026
- Next accounts made up to
- 31/12/2025
- Last accounts made up to
- 31/12/2024
AMBER THERAPEUTICS LIMITED
Active- 02826839Copy
Copy
Registry details
Reference data exactly as held at Companies House.
Copy registry details
- Registered office
- Unit 1 Tech Foundry 2, Curie Avenue, Didcot OX11 0QQ
- Classification (SIC)
- Research and experimental development on biotechnology (72.11 - SIC 2007)
- Accounts type
- Total Exemption Full
Company activity
The 4 most recent documents filed at Companies House.
Pre-Score for UK companies is coming soon
- 19/06/2026View PDF (3 pages)
Confirmation statement made on 2026-06-14 with no updates
- 03/11/2025View PDF (35 pages)
Memorandum and Articles of Association
- 03/11/2025View PDF (1 pages)
Resolutions
- 03/11/2025View PDF (2 pages)
Statement of company's objects
Coming soon
What Pre-Score will tell you
- Whether the filed accounts are strengthening or weakening year on year.
- Whether this company files on time, and how often its record changes.
- How its officers and controlling parties connect to other UK companies.
Accounts and confirmation statement
The two filings Companies House requires every year, and where each one stands against its deadline today.
Due in 4 days
Confirmation statement
Confirms the registry record is up to date
- Next statement date
- 14/06/2026
- Last statement dated
- 31/12/2024
Financial performance
The latest figures AMBER THERAPEUTICS LIMITED filed. Okredo holds filed accounts data for 2021–2024; the year-by-year record is on the financials page.
Net Assets
£-3.79M2024
-1.06K%vs 20232023: £-327.01K
Total Assets
£14.40M2024
5.79K%vs 20232023: £244.55K
Cash in Bank
£13.27M2024
22.25K%vs 20232023: £59.36K
Total Liabilities
£17.99M2024
3.15K%vs 20232023: £554.11K
Employees
242024
+21vs 20232023: 3
Of the 4 measures with an earlier filing to compare against, 3 rose and 1 fell. Total liabilities moved furthest, up 3.15K% on 2023. See the full financial analysis for AMBER THERAPEUTICS LIMITED.
The full financial record
Four ways through AMBER THERAPEUTICS LIMITED's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Cash in Bank · +1423% a year (CAGR)Three-year trend, 2022–2024Every measure end to end across 2022, 2023 and 2024, with the compound rate behind each one.See what moved5 chartsCharts by indicator5 filed indicators plotted year by year, 2021–2024.Plot the figuresNothing estimatedRatios from the filed figures4 ratios computed from this company's own reported amounts, each shown against the year it was derived from.Check the ratios5 × 4 yearsEvery figure by yearAll 5 measures Okredo tracks across 4 reported years, exactly as filed.Open the table
Employees
Headcount as reported to Companies House for 2021–2024.
| Year | Employees | Change |
|---|---|---|
| 2024 | 24 | +21 |
| 2023 | 3 | -3 |
| 2022 | 6 | 0 |
| 2021 | 6 | – |
Reported employee count increased from 6 in 2021 to 24 in 2024. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
- Company potential
- Risk indicators
- Past performance
- Future prospects
Officers
13Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Nominee Secretary | 14/06/1993–14/06/1993 | 99601 | |
| Director | 14/06/1993–27/08/2014 | 2 | |
| Director | 27/08/2014–28/03/2018 | 11 | |
| Director | 12/06/2018–25/07/2023 | 14 | |
| Director | 25/07/2023–Present | 4 | |
| Director | 14/06/1993–14/06/1994 | 0 | |
| Secretary | 14/06/1993–01/01/2000 | 1 | |
| Director | 01/02/2005–25/07/2023 | 0 | |
| Secretary | 30/06/2003–25/07/2023 | 0 | |
| Secretary | 01/01/2000–30/06/2003 | 0 | |
| Director | 01/01/2000–30/06/2003 | 3 | |
| Director | 12/06/2018–31/10/2019 | 1 | |
| Director | 25/07/2023–05/02/2025 | 3 |
Persons with significant control
2Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 22/07/2024–Present | 2 | |
| 30/06/2018–22/07/2024 | 0 |
Filing history and recent activity
Every document on the Companies House record, newest first.
- Filings on record
- 30 Since 30/03/2023
- Last 12 months
- 9 +2 vs the year before
- Most recent filing
- 19/06/2026 3 months ago
What changed in the last year
- Confirmation statementLatest 19/06/2026
- Officer changesLatest 31/10/2025
- Share capital (2)Latest 31/10/2025
Filing timeline
- 19/06/2026View PDF (3 pages)
Confirmation statement made on 2026-06-14 with no updates
- 03/11/2025View PDF (35 pages)
Memorandum and Articles of Association
- 03/11/2025View PDF (1 pages)
Resolutions
- 03/11/2025View PDF (2 pages)
Statement of company's objects
- 31/10/2025View PDF (1 pages)
Solvency Statement dated 30/10/25
- 31/10/2025View PDF (1 pages)
Statement by Directors
- 31/10/2025View PDF (1 pages)
Resolutions
- 31/10/2025View PDF (3 pages)
Statement of capital on 2025-10-31
- 30/10/2025View PDF (3 pages)
Statement of capital following an allotment of shares on 2025-10-30
- 05/09/2025View PDF (17 pages)
Total exemption full accounts made up to 2024-12-31
- 27/06/2025View PDF (1 pages)
Cessation of Bioinduction Medical Ltd as a person with significant control on 2024-07-22
- 27/06/2025View PDF (2 pages)
Notification of Amber Therapeutics Holdings Limited as a person with significant control on 2024-07-22
Showing 12 of 30 filings
See when the next accounts and confirmation statement are due
Similar companies
34 UK companies are similar to AMBER THERAPEUTICS LIMITED, sharing the same company status (Active), the same industry sector and activity group (Research and experimental development on biotechnology) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
CERES HOLOGRAPHICS LIMITED
ActiveSuite 2, Ground Floor Orchard Brae House, 30 Queensferry Road, Edinburgh EH4 2HS
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- SC330746
- Incorporated
- 11/09/2007
- Employees
- 22
WEATHERDEN LIMITED
Active264 Banbury Road, Oxford OX2 7DY
- Activity
- Research and experimental development on biotechnology
- Company no.
- 09241011
- Incorporated
- 30/09/2014
- Employees
- 29
LIVER RESEARCH AND DEVELOPMENT LIMITED
Active111 Coldharbour Lane, London SE5 9NT
- Activity
- Research and experimental development on biotechnology
- Company no.
- 07944232
- Incorporated
- 09/02/2012
- Employees
- 21
A.M.S. BIOTECHNOLOGY (EUROPE) LIMITED
ActiveMunro House Trafalgar Way, Bar Hill, Cambridge CB23 8SQ
- Activity
- Research and experimental development on biotechnology
- Company no.
- 02117791
- Incorporated
- 31/03/1987
- Employees
- 22
BASECAMP RESEARCH LTD
ActiveUnit 315, Clerkenwell Workshops 27 Clerkenwell Close, London EC1R 0AT
- Activity
- Research and experimental development on biotechnology
- Company no.
- 12354133
- Incorporated
- 09/12/2019
- Employees
- 26
About AMBER THERAPEUTICS LIMITED
A short description of the company, written from its Companies House record.
AMBER THERAPEUTICS LIMITED is a private limited company registered in the United Kingdom, based in Unit 1 Tech Foundry 2, Curie Avenue, Didcot OX11 0QQ. Companies House classifies its business as Research and experimental development on biotechnology. It has been on the register for 33 years 3 months.
The register currently records it as active. Its 2024 accounts report net assets of £-3.79M and 24 employees.
AMBER THERAPEUTICS LIMITED: frequently asked questions
Answered from this company's own registry record and filed figures.
What does AMBER THERAPEUTICS LIMITED do?
Companies House records AMBER THERAPEUTICS LIMITED under one registered business activity: Research and experimental development on biotechnology (72.11 - SIC 2007).
Is AMBER THERAPEUTICS LIMITED still active?
AMBER THERAPEUTICS LIMITED is recorded as active on the Companies House register, and has been on it since 14/06/1993.
What are AMBER THERAPEUTICS LIMITED's latest reported financials?
The most recent accounts Okredo holds cover 2024 and report net assets of £-3.79M, total assets of £14.40M, cash in bank of £13.27M and total liabilities of £17.99M.
When did AMBER THERAPEUTICS LIMITED last file with Companies House?
The most recent document on the record is dated 19/06/2026: Confirmation statement made on 2026-06-14 with no updates, 3 months ago.
When are AMBER THERAPEUTICS LIMITED's next filings due?
On the current registry record, accounts are due by 30/09/2026.
Who runs AMBER THERAPEUTICS LIMITED?
Companies House lists 13 officers (1 currently in post) and 2 people with significant control (1 current).